CA1340552C - O-chloroacetylcarbamoylfumagillol; methode de preparation et utilisationde ce compose - Google Patents

O-chloroacetylcarbamoylfumagillol; methode de preparation et utilisationde ce compose

Info

Publication number
CA1340552C
CA1340552C CA000617081A CA617081A CA1340552C CA 1340552 C CA1340552 C CA 1340552C CA 000617081 A CA000617081 A CA 000617081A CA 617081 A CA617081 A CA 617081A CA 1340552 C CA1340552 C CA 1340552C
Authority
CA
Canada
Prior art keywords
fumagillol
reaction
chloroacetylcarbamoylfumagillol
compound
base
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA000617081A
Other languages
English (en)
Inventor
Shoji Kishimoto
Takeshi Fujita
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Priority to CA000617081A priority Critical patent/CA1340552C/fr
Application granted granted Critical
Publication of CA1340552C publication Critical patent/CA1340552C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/38—Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D303/46—Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals by amide or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/08—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing alicyclic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
CA000617081A 1988-09-01 1997-08-18 O-chloroacetylcarbamoylfumagillol; methode de preparation et utilisationde ce compose Expired - Fee Related CA1340552C (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA000617081A CA1340552C (fr) 1988-09-01 1997-08-18 O-chloroacetylcarbamoylfumagillol; methode de preparation et utilisationde ce compose

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP219287 1988-09-01
JP053537 1989-03-06
CA000617081A CA1340552C (fr) 1988-09-01 1997-08-18 O-chloroacetylcarbamoylfumagillol; methode de preparation et utilisationde ce compose

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA000617081A Division CA1340552C (fr) 1988-09-01 1997-08-18 O-chloroacetylcarbamoylfumagillol; methode de preparation et utilisationde ce compose

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CA000617081A Division CA1340552C (fr) 1988-09-01 1997-08-18 O-chloroacetylcarbamoylfumagillol; methode de preparation et utilisationde ce compose

Publications (1)

Publication Number Publication Date
CA1340552C true CA1340552C (fr) 1999-05-18

Family

ID=33315152

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000617081A Expired - Fee Related CA1340552C (fr) 1988-09-01 1997-08-18 O-chloroacetylcarbamoylfumagillol; methode de preparation et utilisationde ce compose

Country Status (1)

Country Link
CA (1) CA1340552C (fr)

Similar Documents

Publication Publication Date Title
EP0359036B1 (fr) Dérivés de fumagillol
EP0357061B1 (fr) Agent inhibiteur d'angiogenèse
US5180738A (en) Fumagillol derivatives and pharmaceutical compositions thereof
US5164410A (en) Fumagillol derivatives and pharmaceutical compositions thereof
US5166172A (en) Fumagillol derivatives and pharmaceutical compositions thereof
US5290807A (en) Method for regressing angiogenesis using o-substituted fumagillol derivatives
US6017954A (en) Method of treating tumors using O-substituted fumagillol derivatives
CA3058214A1 (fr) Saxitoxines 11,13-modifiees destinees au traitement de la douleur
US4877808A (en) Novel β-D-phenylthioxylosides, their method of preparation and their use as therapeutics
EP0736029B1 (fr) Sulfamates de pseudofructopyranose anticonvulsifs
KR840001808B1 (ko) 아데닌 뉴클레오시드 유도체의 제조방법
US4381400A (en) Process for the synthesis of isosorbide mononitrates
CA1340552C (fr) O-chloroacetylcarbamoylfumagillol; methode de preparation et utilisationde ce compose
WO1990008539A1 (fr) Analogues de myo-inositol et leurs modes d'emploi
US6180664B1 (en) Pentaerythritol derivatives, their production and use and intermediates for their synthesis
NZ224565A (en) Epipodophyllotoxin glucoside derivatives; use in antitumour medicaments
US4794115A (en) Method of treating hyperlipemia
EP0026000B1 (fr) Composés spiranniques, procédé pour leur préparation et compositions pharmceutiques les contenant
Fringuelli et al. A Simple Procedure for the Synthesis of Labile Aryl Oxiranes by Epoxidation
e Silva et al. Synthesis and cytotoxic activity of N-substituted thiosemicarbazones of 3-(3, 4-methylenedioxy) phenylpropanal
US3950324A (en) D-glucose-1-0-nicotinoyl-2-deoxy-2-nictinamido derivatives
EP0204172B1 (fr) Dérivés de phénylpyrazine, leurs procédés de préparation, composition pharmaceutique at utilisation
FI73210B (fi) Foerfarande foer framstaellning av 2-alkoximetylderivat av pyrazin-4-oxid.
JPH0660168B2 (ja) ０―置換フマギロール誘導体
JPS6024102B2 (ja) ５−フルオロウラシル誘導体の製法

Legal Events

Date Code Title Description
MKLA Lapsed